Thymosin Beta-4 (TB4)

Thymosin beta-4 (TB4) is a peptide molecule expressed during embryonic development and in adults, capable of increasing myocardial cell migration, endothelial cell proliferation, and capillary formation. Systemic injection of TB4 improves post-ischemic cardiac function in adult mammals, inhibits myocardial cell death, initiates coronary re-growth and activates endogenous vessel and myocardial progenitor cells of the adult heart. TB4 is able to reactivate the embryonic program of the adult mammalian heart, and the regenerative capacity is independent of injury. Researchers propose that postnatal administration of developmentally relevant candidate molecules, such as TB4, may accelerate organ regeneration and reverse aging processes.

TB4 (Thymosin Beta 4) and TB500 are related peptides, but they are not identical.

Key differences:

TB4: This is a naturally occurring peptide made up of 43 amino acids. It plays a role in tissue repair, wound healing, and inflammation reduction. TB4 is encoded by the TMSB4X gene and has a wide range of functions in the body, including actin sequestration and cell proliferation.

TB500: This is a synthetic version of TB4, specifically a fragment consisting of a sequence of amino acids found in TB4. It shares many of the properties of TB4, particularly those related to cell proliferation, differentiation, and migration. However, TB500 is a smaller peptide and does not have the full range of properties that TB4 possesses.

Both TB4 and TB500 have been researched for their potential healing benefits, but TB4 is generally considered to be more effective due to its broader range of properties.